MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $409 | -36.8% | 2,800 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $647 | -29.8% | 2,800 | -26.3% | 0.00% | -40.0% |
| Q1 2023 | $921 | -16.5% | 3,800 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $1,103 | -99.6% | 3,800 | 0.0% | 0.01% | +250.0% |
| Q3 2022 | $247,000 | -9.2% | 3,800 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $272,000 | -27.1% | 3,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $373,000 | +15.8% | 3,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $322,000 | +49.8% | 3,800 | +40.7% | 0.00% | +100.0% |
| Q3 2021 | $215,000 | -18.3% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $263,000 | -6.4% | 2,700 | +12.5% | 0.00% | -50.0% |
| Q1 2021 | $281,000 | +5.2% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $267,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |